MBMarion Bosc

Marion Bosc

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marion Bosc has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Du doute à la vérification : étude comportementale et électrophysiologique de la prise de décision chez le primate non-humain

    by Marion Bosc

    La vérification est un comportement volontaire mis en place à la suite d’un doute ou de la détection d’une erreur au cours d’une prise de décision. De très rares études se sont intéressées aux bases physiologiques de ce comportement, la majorité des travaux étant basés sur l’analyse des comportements pathologiques, comme les vérifications associées au trouble obsessionnel compulsif. Ces travaux de thèse ont consisté à déterminer les bases neurobiologiques du comportement de vérification chez le primate non-humain, un modèle de choix dans l’étude de la physiopathologie humaine. Pour cela deux singes macaque rhésus ont été entrainés à la tâche « Check-or-Go » permettant aux sujets de vérifier et éventuellement modifier la disponibilité d’une récompense avant de confirmer la décision afin d’accéder à cette même récompense. A l’aide d’une analyse comportementale, de dosages d’un biomarqueur de l’anxiété, d’enregistrements EEG du cortex préfrontal et d’enregistrements extracellulaires unitaires au niveau de CMAr et pré-SMA, nous avons pu montrer que : (i) les singes ont les capacités métacognitives d’exprimer un comportement volontaire de vérification similaire à celui observé chez l’Homme, (ii) ce comportement est sous tendu par l’émergence du doute, (iii) est corrélé au niveau d’anxiété, et (iv) est associé à des mécanismes cognitifs mettant en jeu le cortex préfrontal, et plus spécifiquement CMAr et pré-SMA.

  • Open Access

    The antipsychotic drug clozapine suppresses autoimmunity driving psychosis-like behavior in mice

    by Le He, Harriet Feldman, Timothy Nguyen, Marion Bosc, Vasishta Polisetty, Orla Kriel, Antonia Landwehr, Annabel Borg, Fernanda Teixera Subtil, Mohammadparsa Khakpour, et al.

    Antipsychotic drugs are the first-line treatment for psychosis yet their mechanism of action remains poorly understood, largely due to the challenge to faithfully model psychosis preclinically. Here, we focus on the emerging concept that psychosis can be caused by brain autoimmunity and present a novel mouse model of anti-N-methyl-D-aspartate-receptor (anti-NMDAR) encephalitis, a condition that manifests with psychosis and autoantibodies against the NMDAR. We devised a new mRNA-based approach to immunize mice against the NMDAR. Immunized mice developed psychosis-like behaviors that were caused by anti-NMDAR autoantibodies leading to phagocytosis of NMDARs by brain micro-glia. The antipsychotic drug clozapine rescued psychosis-like behaviors and, remarkably, reduced anti-NMDAR autoantibody levels and antibody-mediated phagocytosis of NMDARs. The immunomodulato-ry effects of clozapine were confirmed in a mouse model of systemic lupus erythematosus. Our results demonstrate that clozapine suppresses autoimmunity driving psychosis-like behaviors, raising the possibility that immunomodulation contributes to antipsychotic drug action.


  • Open Access

    Bounded optimality of time investments in rats, mice, and humans

    by Torben Ott, Marion Bosc, Joshua I. Sanders, Paul Masset, Adam Kepecs

    Time is our scarcest resource. Allocating time optimally presents a universal challenge for all organisms because the future benefits of time investments are uncertain. We developed a normative framework for assessing bounded optimality in time allocation, emphasizing the accuracy of future predictions, independent of subjective costs and benefits. In a common decision task across humans, rats, and mice, we varied uncertainty by titrating ambiguous sensory evidence and measured the time each subject was willing to invest post-decision. We observed that all species and subjects invested more time when they were more likely to be correct, which reflected a statistical confidence of uncertain evidence. Time allocation strategy approached the lower bound of optimality, indicating an accurate decision-by-decision assessment of confidence in the likelihood that waiting will pay off – independent of the subjective payoff values and time costs. We demonstrate that an elementary algorithm based on a drift-diffusion process algorithm can implement this optimal time investment strategy. These results illuminate the computational mechanisms governing rational time investment, showing that humans, rats, and mice can maximize payoffs via confidence-guided time allocation. Highlights Computational and behavioral framework to assess bounded optimality of investments. Humans, rats, and mice invest more time to obtain more likely payoffs, in proportion to statistical confidence. Time investment was close to optimal model predictions, reflecting bounded optimality of investments under uncertainty. Bounded-optimal time investment may be an evolutionary ancient adaptive behavioral strategy.

  • Lack of limbic-predominant age-related TDP-43 encephalopathy (LATE) neuropathological changes in aged macaques with memory impairment

    by Morgane Darricau, Marie-Hélène Canron, Marion Bosc, Marie-Laure Arotçarena, Mégane Le Quang, Benjamin Dehay, Erwan Bezard, Vincent Planche


  • Top Cited Papers

    Striatal dopamine mediates hallucination-like perception in mice

    by K. Schmack, M. Bosc, T. Ott, J. F. Sturgill, A. Kepecs

    How to model hallucinations in mice: There has not been enough progress in our understanding of the basic mechanisms underlying psychosis. Studying psychotic disorders in animal models is difficult because the diagnosis relies on self-reported symptoms that can only be assessed in humans. Schmack et al. developed a paradigm to probe and rigorously measure experimentally controlled hallucinations in rodents (see the Perspective by Matamales). Using dopamine-sensor measurements and circuit and pharmacological manipulations, they demonstrated a brain circuit link between excessive dopamine and hallucination-like experience. This could potentially be useful as a translational model of common psychotic symptoms described in various psychiatric disorders. It may also help in the development of new therapeutic approaches based on anatomically selective modulation of dopamine function. Science , this issue p. eabf4740 ; see also p. 33


  • Does the Serotonin2C receptor segregate circuits of the basal ganglia responding to cingulate cortex stimulation?

    by Mélanie Lagière, Marion Bosc, Sara Whitestone, Julien Manem, Hasna Elboukhari, Abdelhamid Benazzouz, Giuseppe Di Giovanni, Philippe De Deurwaerdère


  • Open Access

    Checking behavior in rhesus monkeys is related to anxiety and frontal activity

    by Marion Bosc, Bernard Bioulac, Nicolas Langbour, Tho Hai Nguyen, Michel Goillandeau, Benjamin Dehay, Pierre Burbaud, Thomas Michelet

    When facing doubt, humans can go back over a performed action in order to optimize subsequent performance. The present study aimed to establish and characterize physiological doubt and checking behavior in non-human primates (NHP). We trained two rhesus monkeys (Macaca mulatta) in a newly designed “Check-or-Go” task that allows the animal to repeatedly check and change the availability of a reward before making the final decision towards obtaining that reward. By manipulating the ambiguity of a visual cue in which the reward status is embedded, we successfully modulated animal certainty and created doubt that led the animals to check. This voluntary checking behavior was further characterized by making EEG recordings and measuring correlated changes in salivary cortisol. Our data show that monkeys have the metacognitive ability to express voluntary checking behavior similar to that observed in humans, which depends on uncertainty monitoring, relates to anxiety and involves brain frontal areas.


  • Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology

    by P. De Deurwaerdère, M. Lagière, M. Bosc, S. Navailles

    Serotonin2C (5-HT2C) receptors are expressed in the basal ganglia, a group of subcortical structures involved in the control of motor behaviour, mood and cognition. These receptors are mediating the effects of 5-HT throughout different brain areas via projections originating from midbrain raphe nuclei. A growing interest has been focusing on the function of 5-HT2C receptors in the basal ganglia because they may be involved in various diseases of basal ganglia function notably those associated with chronic impairment of dopaminergic transmission. 5-HT2C receptors act on numerous types of neurons in the basal ganglia, including dopaminergic, GABAergic, glutamatergic or cholinergic cells. Perhaps inherent to their peculiar molecular properties, the modality of controls exerted by 5-HT2C receptors over these cell populations can be phasic, tonic (dependent on the 5-HT tone) or constitutive (a spontaneous activity without the presence of the ligand). These controls are functionally organized in the basal ganglia: they are mainly localized in the input structures and preferentially distributed in the limbic/associative territories of the basal ganglia. The nature of these controls is modified in neuropsychiatric conditions such as Parkinson’s disease, tardive dyskinesia or addiction. Most of the available data indicate that the function of 5-HT2C receptor is enhanced in cases of chronic alterations of dopamine neurotransmission. The review illustrates that 5-HT2C receptors play a role in maintaining continuous controls over the basal ganglia via multiple diverse actions. We will discuss their interest for treatments aimed at ameliorating current pharmacotherapies in schizophrenia, Parkinson’s disease or drugs abuse.


  • Open Access

    Serotonin2C Receptors and the Motor Control of Oral Activity

    by Melanie Lagiere, Sylvia Navailles, Marion Bosc, Martin Guthrie, Philippe Deurwaerdere

    Data from many experiments has shown that serotonin2C (5-HT2C) receptor plays a role in the control of orofacial activity in rodents. Purposeless oral movements can be elicited either by agonists or inverse agonists implying a tight control exerted by the receptor upon oral activity. The effects of agonists has been related to an action of these drugs in the subthalamic nucleus and the striatum, the two input structures for cortical efferents to the basal ganglia, a group of subcortical structures involved in the control of motor behaviors. The oral effects of agonists are dramatically enhanced in case of chronic blockade of central dopaminergic transmission induced by neuroleptics or massive destruction of dopamine neurons. The mechanisms involved in the hypersensitized oral responses to 5-HT2C agonists are not clear and deserve additional studies. Indeed, while the oral behavior triggered by 5-HT2C drugs would barely correspond to the dyskinesia observed in humans, the clinical data have consistently postulated that 5-HT2C receptors could be involved in these aberrant motor manifestations.